Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/44529
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients
Author: Westley, I.
Taylor, P.
Salm, P.
Morris, R.
Citation: Therapeutic Drug Monitoring, 2007; 29(5):584-591
Publisher: Lippincott Williams & Wilkins
Issue Date: 2007
ISSN: 0163-4356
1536-3694
Abstract: The immunosuppressant drug tacrolimus has a narrow therapeutic index and is subject to a large variation in individual bioavailability and clearance. With its narrow therapeutic index, therapeutic drug monitoring is standard clinical practice in the management of transplant recipients. In this study, we report the evaluation of the cloned enzyme donor immunoassay (CEDIA) for the determination of whole-blood tacrolimus concentrations compared with high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) and microparticle enzyme immunoassay (MEIA) using samples obtained from liver (n = 100) and renal (n = 88) transplant recipients. Linear regression analysis showed a relationship of CEDIA = 1.24 HPLC-MS/MS -0.18 (r = 0.81). The mean bias (+/-SEM) for all patients when compared with HPLC-MS/MS was 22.2% (+/-2.1%). The precision of the CEDIA method for all samples showed a root mean square error of 3.1 microg/L. Liver transplant recipient samples showed a mean (+/-SEM) bias compared with HPLC-MS/MS of 12.5% (+/-1.6%). The precision of the CEDIA method for these samples showed a root mean square error of 1.5 microg/L. The data suggest that in the renal transplant group, the CEDIA and MEIA methods have a bias of 33.3% and 20.1%, respectively, compared with HPLC-MS/MS. The CEDIA tacrolimus immunoassay has been shown to be a rapid method for the determination of whole-blood tacrolimus concentrations and may be considered when HPLC-MS/MS is not available. When used in the clinical setting with other parameters, it would be a useful adjunct in the management of liver transplant recipients, but a significant bias in renal transplant patients needs to be further investigated.
Keywords: Clone Cells; Humans; Tacrolimus; Immunosuppressive Agents; Drug Monitoring; Immunoenzyme Techniques; Kidney Transplantation; Liver Transplantation; Chromatography, High Pressure Liquid; Reproducibility of Results; Adolescent; Adult; Aged; Middle Aged; Child; Female; Male; Mass Spectrometry
Description: Copyright © 2007, Lippincott Williams & Wilkins. All rights reserved.
RMID: 0020073037
DOI: 10.1097/FTD.0b013e31811f25df
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.